Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natulan (Procarbazine) in Advanced Hodgkin's Lymphoma
NCT02800447Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Jun 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of procarbazine in Hodgkin lymphoma (HL) (2 arms), sponsored by Lee's Pharmaceutical Holdings Limited. Primary endpoint: Overall Response Rate at 45 months. Status: unknown.
02
Drugs
procarbazine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT02800447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02800447.